Upstart
Upstart
Upstart launches and invests primarily in early-stage healthcare companies with disruptive, market-shifting technologies.
- Use:
- Date closing: -
- Amount: -
- Industry focus: Health; Others;
- Total budget: 100M $
- Entity type: Venture Capital
- Vertical focus: climate tech
- Website: https://www.upstartvc.com/
- Status: Open
- Funding type: Equity investment;
- Geographic focus:
- Public/Private: Private
- Stage focus: Seed;
- Applicant target: Startup;
Overview
Founded in 2009, UpStart Ventures is headquartered in Salt Lake City, Utah. Their investment strategy represents a unique combination of idea generation, science discovery, seed stage investing, venture judgment and company management.
Their first fund, UpStart Life Sciences Capital, L.P. invests primarily in seed and early-stage healthcare companies, based on breakthrough technologies from major research universities, centered around Utah and neighboring states.
They invest in opportunities such as medical devices, drug delivery systems, and diagnostics, as well as longer range investments in biopharma products and platforms.
Despite an impressive array of life science technologies that have spun out from universities in the region, UpStart is alone in exclusively focusing on seed and early-stage opportunities life science investing.
Recently, they have launched their latest fund that amounts to $100M.
Portfolio: Elute, Photopharmics, Sera Prognostics, Q Therapeutics.
Upstart FAQ
Upstart Reviews
Recommend to a Friend
Experience
No data experience
Getting the funds
No data getting funds
Simple process
Upstart News
Featured Funds
- Usage: R&D; Go2Market;
- Entity type: Public Agency
- Funding type: Grant;
- Geographic focus: Sweden;
- 0 reviews 0 questions
- Usage: R&D; Go2Market; Social & Environment; Other;
- Entity type: Public Agency
- Total: 8B €
- Funding type: Equity investment;
- Status: Open
- Geographic focus: Spain;
- 0 reviews 1 questions
- Usage: Go2Market;
- Entity type: Accelerator
- Funding type: Equity investment;
- Status: Open
- Geographic focus: Global;
- Deadline: February 28, 2022
- 0 reviews 0 questions